CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Operating activities:
Net income	$ 823	$ 497	$ 1,208
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and accretion	150	148	124
Stock-based compensation expense	657	555	398
Deferred income taxes	(277)	(8)	(779)
Lease-related asset impairments	34	104	0
Other operating activities	(8)	18	39
Changes in operating assets and liabilities, net of business combinations:
Accounts receivable	(247)	(66)	13
Prepaid expenses and other assets	(3)	(134)	(56)
Accounts payable and other liabilities	(5)	10	130
Deferred revenue	798	419	344
Accrued income taxes	149	(12)	16
Net cash provided by operating activities	2,071	1,531	1,437
Investing activities:
Purchases of marketable securities	(397)	(311)	(21)
Sales of marketable securities	152	12	0
Maturities of marketable securities	298	26	17
Purchases of intangible assets	(6)	(11)	(5)
Business combinations, net of cash acquired	(96)	(1,250)	(246)
Capital expenditures	(40)	(56)	(91)
Other investing activities	(54)	(5)	(58)
Net cash used in investing activities	(143)	(1,595)	(404)
Financing activities:
Proceeds from issuance of common stock, net of issuance costs	124	114	114
Taxes paid related to net share settlement of equity awards	(160)	(194)	(157)
Repurchase and retirement of common stock	(1,101)	(1,079)	(552)
Proceeds from debt, net of discount	0	997	0
Repayments of debt	(350)	0	(450)
Other financing activities	0	(7)	(2)
Net cash used in financing activities	(1,487)	(169)	(1,047)
Effect of exchange rate changes on cash and cash equivalents	(22)	(11)	11
Net increase (decrease) in cash and cash equivalents	419	(244)	(3)
Cash and cash equivalents at beginning of fiscal year	1,528	1,772	1,775
Cash and cash equivalents at end of fiscal year	1,947	1,528	1,772
Supplemental cash flow disclosure:
Cash paid for interest	86	58	63
Cash paid for income taxes, net of tax refunds	241	165	93
Non-cash investing and financing activities:
Fair value of common stock issued to settle liability-classified restricted stock units	11	3	29
Fair value of common stock issued related to business combination (See Note 6)	$ 10	$ 6	$ 38